Antiprotozoal agents: How have they changed over a decade?
- 18 October 2021
- journal article
- review article
- Published by Wiley in Archiv der Pharmazie
- Vol. 355 (2), e2100338
- https://doi.org/10.1002/ardp.202100338
Abstract
Neglected tropical diseases are a diverse group of communicable diseases that are endemic in low- or low-to-middle-income countries located in tropical and subtropical zones. The number and availability of drugs for treating these diseases are low, the administration route is inconvenient in some cases, and most of them have safety, efficacy, or adverse/toxic reaction issues. The need for developing new drugs to deal with these issues is clear, but one of the most drastic consequences of this negligence is the lack of interest in the research and development of new therapeutic options among major pharmaceutical companies. Positive changes have been achieved over the last few years, although the overall situation remains alarming. After more than one decade since the original work reviewing antiprotozoal agents came to light, now it is time to question ourselves: How has the scenario for the treatment of protozoal diseases such as malaria, leishmaniasis, human African trypanosomiasis, and American trypanosomiasis changed? This review covers the last decade in terms of the drugs currently available for the treatment of these diseases as well as the clinical candidates being currently investigated.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
This publication has 207 references indexed in Scilit:
- Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for eliminationMalaria Journal, 2013
- Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping SicknessAntimicrobial Agents and Chemotherapy, 2011
- Artemisinin: Discovery from the Chinese Herbal GardenCell, 2011
- Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparumScientific Reports, 2011
- Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trialThe Lancet Infectious Diseases, 2010
- Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African TrypanosomiasisAntimicrobial Agents and Chemotherapy, 2010
- Chagas disease: A Latin American health problem becoming a world health problemActa Tropica, 2010
- Chagas diseaseThe Lancet, 2010
- Rosiglitazone Modulates the Innate Immune Response toPlasmodium falciparumInfection and Improves Outcome in Experimental Cerebral MalariaThe Journal of Infectious Diseases, 2009
- Antiparasitic compounds that target DNABiochimie, 2008